Insider Stock Trading History of Lichtinger Pedro


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lichtinger Pedro since year 2005. The trader's CIK number is 1470741. At the time of this reporting, Lichtinger Pedro is the Director of Gemphire Therapeutics Inc. . (stock ticker symbol GEMP). See this page for all insider trading activities at Gemphire Therapeutics Inc. .

Note that in the past LICHTINGER PEDRO also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lichtinger Pedro since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-03-10 GEMP Gemphire Therapeutics Inc. Buy 10,559 9.47 99,993
2016-08-10 GEMP Gemphire Therapeutics Inc. Buy 10,000 10.00 100,000
2015-02-09 AST Asterias Biotherapeutics, Inc. Buy 128,205 3.90 499,999
2013-06-04 BTX Biotime Inc Buy 120,000 .00 0
2013-04-08 OPTR Optimer Pharmaceuticals Inc Sale 148,000 14.68 2,172,344
2013-04-08 OPTR Optimer Pharmaceuticals Inc Option Ex 148,000 12.46 1,844,080
2012-11-08 OPTR Optimer Pharmaceuticals Inc Buy 11,000 9.08 99,847
2012-04-11 BTX Biotime Inc Buy 6,250 3.98 24,850
2011-08-04 OPTR Optimer Pharmaceuticals Inc Buy 25,000 8.98 224,450

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lichtinger Pedro (Director of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.